Surgery FFP Flashcards
Fibroadenomas - presentation, examination, diagnosis, treatment
Aberrations of Normal Development and Involution (ANDI)
Benign breast condition
younger patients - 20s
smooth, very mobile, “breast mouse”, can be tender, firm rubbery, can change over menstruation
diagnoses using triple assessment; US, mammogram, clinically and core biopsy
left alone or removed if too big; surgery/vacuum excision
Breast cysts - presentation, examination, diagnosis, treatment
Aberrations of Normal Development and Involution (ANDI)
Benign breast condition
30-50; 50+ if on HRT
Lump +/- pain with cyclical fluctuation
Smooth, mobile lump, can be tender
Triple assessment; US, mammogram, clinically and core biopsy
Left alone if asymptomatic or simple drainage
Fibroadenosis presentation, examination, diagnosis, treatment
Aberrations of Normal Development and Involution (ANDI)
“Benign breast changes” - Benign breast condition
Lumpiness +/- pain with cyclical fluctuation
Thickening +/- tenderness
Fat necrosis presentation, examination, diagnosis,
Any age
Trauma (surgery, accident) except in older women; can be small hits
Could feel benign (solid/cystic) or malignant +/- bruise
Triple assessment
What tests should be done for pts less than 40 vs those older than 40 with suspected breast cancer
<40 => Ultrasound
40< => Ultrasound and mammogram
This is due to younger patients breasts being too dense for mammograms to be of use.
Types of nipple discharge and when it may be significant
Milky discharge or galactorrhoea is often due to hyperprolactinaemia, which may point to an underlying endocrine condition so the patient should be managed accordingly.
Pus discharging from the nipple is often part of an infection such as periductal mastitis, so should be managed accordingly.
Significant/Pathological :
Spontaneous
Persistent
Unilateral
Single-duct
Insignificant/Physiological :
Provoked
intermittent
bilateral
multi-duct
For unilateral and single-duct discharge, the commonest underlying pathology is …..
and treatment
For unilateral and single-duct discharge, the commonest underlying pathology is a duct papilloma, which is again a benign condition. However ductal carcinoma in situ (DCIS) could also present this way.
In the absence of any abnormal radiological findings (mammogram and ultrasound), if we are still worried, we will tend to operate by removing the discharging duct (a procedure called microdochectomy) for histological examination. That will also treat the symptom of discharge.
Breast pain - facts and questions to ask, next steps
Pain alone is rarely due to breast cancer
- Is it Disturbing vs non-disturbing life activities
- Cyclical vs non-cyclical
We do not normally have to carry out radiological examination except for a screening mammogram if the patient falls into the age group who will benefit from this (40 years onward).
Breast infections (two main ones)
History
Physical findings
Pathogens
Investigations
Management
Lactational mastitis/abscess
History of lactation
Found Peripherally, Deep with Acute inflammation
S. aureus
US if ?abscess
Antibiotic (flucloxacillin) +/- drainage* + C/ST
Breast feeding can continue
Periductal mastitis/abscess
20s-40s, Chronic smoker, Recurrent episodes
Found Peri-areolar, Superficial, Chronic inflammation (scarring, fistula)
Mixed, including anaerobes
US if ?abscess
Antibiotic (co-amoxiclav) +/- drainage* + C/ST
↓Smoking
?Surgery
Most common types of breast cancer
Invasive Ductal carcinoma, followed by lobular
DC in situ
Breast cancer risk factors
Female
Age
BRCA
Direct family history
Radiation
Past breast surgeries
alcohol
Combined contraceptives
increased exposure to oestrogen
Breast cancer presentation, examination, diagnosis
Hard, immobile lump, rough borders, non-tender
Triple assessment
At risk pathologies for breast cancer
At-risk pathology: Atypical Ductal hyperplasia, ALH, LCIS, papillomatosis.
Types of pathology tests for breast cancer
Pathological assessment is done by biopsy.
Fine needle aspiration (FNA) cytology - gives you cell morphology
Needle core biopsy, which is now preferred, gives you tissue architecture.
Angles for mammogram
The standard views are cranio-caudal (CC) and oblique, so you broadly cover two dimensions, but also include the axilla – pectoral muscles as shown here in an oblique view, which shows a mass with irregular border in the upper aspect of the breast near the axilla.
Following radiology, the results for a breast lump are defined as either (5)
Normal
Benign Indeterminate
Suspicious
Malignant
TMN Staging for breast cancer
T (Primary Tumor):
T0: No evidence of primary tumor.
Tis: Carcinoma in situ (non-invasive cancer).
T1: Tumor size ≤2 cm
T2: Tumor size >2 cm but ≤5 cm
T3: Tumor size >5 cm
T4: Tumor of any size invading nearby structures (e.g., chest wall or skin)
N (Regional Lymph Nodes):
NX: Regional lymph nodes cannot be assessed.
N0: No regional lymph node involvement.
N1: regional lymph node involvement.
N2: distant nodes
M (Distant Metastasis):
M0: No distant metastasis.
M1: Distant metastasis present.
Manchester 4 stage classification of breast cancer
1 - confined to breast
2 - breast and mobile axillary nodes
3 - growth beyond mammary parenchyma
4 - growth beyond breast area
What is the commonest first site of distant metastasis in breast cancer?
Bone
Two broad groups of inoperable breast cancers and management
Locally advanced primary disease – The tumour is inoperable e.g. fungating or ulcerated tumour, tumour fixed to the pectoralis major muscle or chest wall, or inflammatory cancer, but has NOT yet spread to distant sites. There are two distinct points in terms of the principles of managing this group – (i) Since the chance of asymptomatic distant metastases is higher than in early operable disease, we normally do some staging investigations like a CT scan of the chest, abdomen and pelvis, prior to starting treatment; (ii) the initial treatment tends to be systemic such as chemotherapy (or we call it neoadjuvant chemotherapy) with a view of down-staging the cancer to allow surgery.
- Metastatic breast cancer – The disease is no longer curable so the goal of treatment is palliative aiming at improving quality of life.
Management of primary breast cancer - surgery
In general, surgery is performed as the INITIAL treatment, followed by what we call adjuvant therapies.
Locoregional control
Obtaining information»_space;> Adjuvant therapies
Cosmesis
Breast - masectomy or wide local incision; if unifocal and small
Axilla - sentinel lymph node (first to spread to) biopsy; identified using radioisotopes or a dye which fails to clear and can be identified by a surgeon.
- If positive: axillary clearance
Management of primary breast cancer - adjuvant therapies
Radiotherapy to affected area if tolerated;
Reasons that they might not tolerate could be previous radiotherapy (like a previous breast cancer, radiotherapy to treat mediastinal lymphoma as a child, or some collagen vascular disease associated with increased skin toxicity eg scleroderma, or that the patient has significant shoulder restriction so the external beam radiation can’t be delivered with her arm stretched
Factors to consider endocrine therapy
The most important ones which we use clinically for making a decision about adjuvant systemic therapies are oestrogen receptor (ER) and human epidermal growth receptor 2 (HER2).
Most invasive breast carcinomas are ER+ (about one-third overall) and only about 15% are HER2+.
Systemic therapies for breast cancer
Chemotherapy
Endocrine therapy (oestrogen +ve) e.g. tamoxifen pre-menopausal, aromatase inhibitors post menopausal (anastrozole, letrozole, exemestane)
Anti-HER2 targeted therapy e.g. trastuzumab (Herceptin)